Orofacial granulomatosis in children-A challenge for diagnosis and treatment

International Journal of Pediatric Otorhinolaryngology

Volumn 75, Issue 6, 2011, Pages 864-867

  Kolho, Kaija Leena ^a   Heiskanen, Kaarina ^a   Verkasalo, Matti ^a,b   Pitkäranta, Anne ^b  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Crohn's disease; Inflammatory bowel disease; Oral inflammation; Swollen lip

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; CETIRIZINE; CHLORHEXIDINE; DAPSONE; GLUCOCORTICOID; METHOTREXATE; METRONIDAZOLE; PREDNISOLONE; TACROLIMUS; TRIAMCINOLONE HEXACETONIDE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CROHN DISEASE; DRUG RESPONSE; FEMALE; HUMAN; MALE; OROFACIAL GRANULOMATOSIS; PRIORITY JOURNAL; SCHOOL CHILD; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; CHILD; FEMALE; GRANULOMATOSIS, OROFACIAL; HUMANS; MALE;

EID: 79955740687     PISSN: 01655876     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijporl.2011.03.003     Document Type: Article

References (22)

1. Tilakaratne W.M., Freysdottir J., Fortune F. Orofacial granulomatosis: review on etiology and pathogenesis. J. Oral Pathol. Med. 2008, 37:191-195.
2. Al Johani K., Moles D.R., Hodgson T., Porter S.R., Fedele S. Onset and progression of clinical manifestations of orofacial granulomatosis. Oral Dis. 2009, 15:214-219.
3. Al Johani K.A., Moles D.R., Hodgson T.A., Porter S.R., Fedele S. Orofacial granulomatosis: clinical features and long-term outcome of therapy. J. Am. Acad. Dermatol. 2010, 62:611-620.
4. Kanerva M., Moilanen K., Virolainen S., Vaheri A., Pitkäranta A. Melkersson-Rosenthal syndrome. Otolaryngol. Head Neck Surg. 2008, 138:246-251.
5. Tonkovic-Capin V., Galbraith S.S., Rogers R.S., Binion D.G., Yancey K.B. Cutaneous Crohn's disease mimicking Melkersson-Rosentahl syndrome: treatment with methotrexate. J. Eur. Acad. Dermatol. Venereol. 2006, 20:449-452.
6. Sanderson J., Nunes C., Escudier M.ym. Oro-facial granulomatosis: Crohn's disease or a new inflammatory bowel disease?. Inflamm. Bowel Dis. 2005, 11:840-846.
7. Saalman R., Mattsson U., Jontell M. Orofacial granulomatosis in childhood-a clinical entity that may indicate Crohn's disease as well as food allergy. Acta Pediatr. 2009, 98:1162-1167.
8. Rowland M., Fleming P., Bourke B. Looking in the mouth for Crohn's disease. Inflamm. Bowel Dis. 2010, 16:332-337.
9. Roseth A.G., Schmidt P.N., Fagerhol M.K. Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granylocyte marker protein, in patients with inflammatory bowel disease. Scand. J. Gastroenterol. 1999, 34:50-54.
10. Sipponen T., Savilahti E., Kolho K.L., Nuutinen H., Turunen U., Färlkkilä M. Crohn's disease activity assessed by fecal calprotectin and lactoferrin: corrleation with Crohn's disease activity index and endoscopic findings. Inflamm. Bowel Dis. 2008, 14:40-46.
11. Armitage E., Drummond H.E., Wilson D.C., Ghosh S. Increasing incidence of both juvenile-onset Crohn's disease and ulcerative colitis in Scotland. Eur. J. Gastroenterol. Hepatol. 2001, 13:1439-1447.
12. Tsironi E., Feakins R.M., Probert C.S., Rampton D.S. Incidence of inflammatory bowel disease is rising and abdominal tuberculosis is falling in Bangladeshis in East London, United Kingdom. Am. J. Gastroenterol. 2004, 99:1749-1755.
13. Turunen P., Kolho K.L., Auvinen A., Iltanen S., Huhtala H., Ashorn M. Incidence of inflammatory bowel disease in Finnish children, 1987-2003. Inflamm. Bowel Dis. 2006, 12:677-683.
14. Castro M., Papadatou B., Baldassare M., Balli F., Barabino A., Barbera C., et al. Inflammmatory bowel disease in children and adolescents in Italy: data from the pediatric national IBD register (1996-2003). Inflamm. Bowel Dis. 2008, 14:1246-1252.
15. van der Waal R.I., Schulten EAm van der Meij E.H., van der Scheur M.R., Starink T.M., van der Waal I. Cheilitis granulomatosa: overview of 13 patients with long-term follow-up results of management. Int. J. Dermatol. 2002, 41:225-229.
16. Migogna M.D., Fedele S., Lo Russo L., Adamo D., Satriano R.A. Effectiveness of small-volume, intralesional, delayed-release triamcinolone injections in orofacial granulomatosis: a pilot study. J. Am. Acad. Dermatol. 2004, 51:265-268.
17. Casson D.H., Eltumi M., Tomlin S., Walker-Smith J.A., Murch S.H. Topical tacrolimus may be effective in the treatment of oral and perineal Crohn's disease. Gut 2000, 47:436-440.
18. Hyams J., Crandall W., Kugathasan S., Griffiths A., Olson A., Johanns J., et al. Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children. Gastroenterology 2007, 132:863-873.
19. Barry O., m Barry J., Langan S., Murphy M., Fitzgibbon J., Lyons J.F. Treatment of granulomatous cheilitis with infliximab. Arch. Dermatol. 2005, 141:1080-1082.
20. Peitsch W.K., Kemmler N., Goerdt S., Goebler M. Infliximab: a novel treatment option for refractory orofacial granulomatosis. Acta Dermatol. Venereol. 2007, 87:265-266.
21. Endo H., Rees T.D. Cinnamon products as a possible etiologic factor in orofacial granulomatosis. Med. Oral Pathol. Oral Cir. Bucal. 2007, 12:E440-444.
22. White A., Nunes C., Escudier M.ym. Improvement in orofacial granulomatosis on a cinnamon- and benzoate-free diet. Inflamm. Bowel Dis. 2006, 12:508-514.